Infection Medicine (BMC)
1381 – 1390 of 1822
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential.
(
- Contribution to journal › Article
-
Mark
Vad gör lärarna när studenternas lärande står i centrum?
2008) NU2008(
- Contribution to conference › Abstract
-
Mark
Implementation of a protein profiling platform developed as an academic-pharmaceutical industry collaborative effort
(
- Contribution to journal › Article
-
Mark
Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages.
(
- Contribution to journal › Article
-
Mark
The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils.
(
- Contribution to journal › Article
- 2007
-
Mark
Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis.
(
- Contribution to journal › Article
-
Mark
M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells
(
- Contribution to journal › Article
-
Mark
Identification of proteins released by mammalian cells that mediate DNA internalization through proteoglycan-dependent macropinocytosis
(
- Contribution to journal › Article
-
Mark
Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation.
(
- Contribution to journal › Article
-
Mark
Protein FOG is a moderate inducer of MIG/CXCL9, and group G streptococci are more tolerant than group A streptococci to this chemokine's antibacterial effect
(
- Contribution to journal › Article